DDD Partners, LLC

Position in ABBV — AbbVie Inc.

CIK 1729673 BELLEVUE, WA

Position in ABBV

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$1,104,196

-$18,773,737 QoQ

Shares Held

4,388

-95.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#2,446

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DDD Partners, LLC holds $28,953,207 across 5 Drug Manufacturers - General names. ABBV ranks #3 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	190,549	$24,485,546
2	GILD	Gilead Sciences, Inc.	13,827	$1,746,903
3	ABBV	AbbVie Inc. This page	4,388	$1,104,196
4	LLY	ELI LILLY & Co	681	$816,811
5	JNJ	Johnson & Johnson	3,149	$799,751

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,104,196	4,388	-95.2%	Shares	Sole	2026-08-05
2026-03-31	$19,877,933	91,397	+3.1%	Shares	Sole	2026-04-28
2025-12-31	$20,253,353	88,640	+0.3%	Shares	Sole	2026-01-22
2025-09-30	$20,469,525	88,406	-17.1%	Shares	Sole	2025-11-06
2025-06-30	$19,801,941	106,680	-5.2%	Shares	Sole	2025-07-31
2025-03-31	$23,575,818	112,523	-10.2%	Shares	Sole	2025-05-02
2024-12-31	$22,273,806	125,345	+9.8%	Shares	Sole	2025-01-31
2024-09-30	$22,547,673	114,177	+0.4%	Shares	Sole	2024-11-12
2024-06-30	$19,496,678	113,670	+0.3%	Shares	Sole	2024-08-01
2024-03-31	$20,632,840	113,305	-14.4%	Shares	Sole	2024-05-09
2023-12-31	$20,503,615	132,307	-0.6%	Shares	Sole	2024-01-18
2023-09-30	$19,844,208	133,129	-1.9%	Shares	Sole	2023-10-18
2023-06-30	$18,279,223	135,673	+9979.7%	Shares	Sole	2023-08-02
2023-03-31	$214,512	1,346	+0.4%	Shares	Sole	2023-05-15
2022-12-31	$216,719	1,341	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.